Eugene Krustev, MD
Johns Hopkins University
Baltimore, Maryland, United States
Disclosure(s): Mountain Valley MD Hldgs: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
Didem Saygin, MD
Rush University Medical Center
Chicago, Illinois, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Julie Paik, MD, MHS
Johns Hopkins University
Baltimore, Maryland, United States
Disclosure(s): ArgenX: Grant/Research Support (Ongoing); Priovant: Grant/Research Support (Ongoing)
May Choi, MD, FRCPC, MPH
University of Calgary
Calgary, Alberta, Canada
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Celltrion: Consultant (Terminated, January 1, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, January 2, 2023); Mallickrodt Pharmaceuticals: Consultant (Terminated, January 2, 2023); MitogenDx: Consultant (Ongoing); Organon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2024); Werfen: Consultant (Ongoing)
To recognize the challenges of treating perimyocardial involvement in various autoimmune diseases. This session will discuss the immunology behind perimyocarditis in various autoimmune rheumatic diseases and provide an update on the latest therapeutics available including the use of biologics.
Speaker: Luigi Adamo, MD, PhD – Johns Hopkins Unviersity
Speaker: Brittany Weber, MD, PhD – Brigham and Women's Hospital
Speaker: Julie Paik, MD, MHS – Johns Hopkins University